Diagnostic nuclear medicine involves the use of radioactive tracers to image and or measure the global or regional function of an organ the radioactive tracer radiopharmaceutical is given to the patient by intravenous injection orally or by other routes depending on the organ and the function to be studied. For most diagnostic studies in nuclear medicine the radioactive tracer is administered to a patient by intravenous injection however a radioactive tracer may also be administered by inhalation by oral ingestion or by direct injection into an organ the mode of tracer administration will depend on the disease process that is to be studied. Vi guide for diagnostic nuclear medicine foreword the nuclear regulatory commission nrc recently revised 10 cfr part 35 which covers the medical use of byproduct material all diagnostic nuclear medicine facilities must reevaluate their procedures and protection programs to determine whether these remain in compliance and what. Nuclear medicine offers the potential to identify disease in its earliest stage often before symptoms occur or abnormalities can be detected with other diagnostic tests by detecting whether lesions are likely benign or malignant pet scans may eliminate the need for surgical biopsy or identify the best biopsy location
How it works:
1. Register Trial Account.
2. Download The Books as you like ( Personal use )